[go: up one dir, main page]

IS6642A - Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum - Google Patents

Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum

Info

Publication number
IS6642A
IS6642A IS6642A IS6642A IS6642A IS 6642 A IS6642 A IS 6642A IS 6642 A IS6642 A IS 6642A IS 6642 A IS6642 A IS 6642A IS 6642 A IS6642 A IS 6642A
Authority
IS
Iceland
Prior art keywords
mtk
disorders
treatment
indole derivatives
derivatives useful
Prior art date
Application number
IS6642A
Other languages
English (en)
Inventor
Bang-Andersen Benny
Felding Jakob
Kehler Jan
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS6642A publication Critical patent/IS6642A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS6642A 2000-06-29 2002-11-29 Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum IS6642A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001018 2000-06-29
PCT/DK2001/000407 WO2002000645A1 (en) 2000-06-29 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
IS6642A true IS6642A (is) 2002-11-29

Family

ID=8159589

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6642A IS6642A (is) 2000-06-29 2002-11-29 Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum

Country Status (23)

Country Link
US (1) US20030232822A1 (is)
EP (1) EP1299380B1 (is)
JP (1) JP2004501912A (is)
KR (1) KR20030011365A (is)
CN (1) CN1439004A (is)
AR (1) AR028736A1 (is)
AT (1) ATE268765T1 (is)
AU (1) AU2001273882A1 (is)
BG (1) BG107471A (is)
BR (1) BR0112286A (is)
CA (1) CA2414115A1 (is)
CZ (1) CZ20024192A3 (is)
DE (1) DE60103761D1 (is)
EA (1) EA200300084A1 (is)
HU (1) HUP0300786A2 (is)
IL (1) IL153254A0 (is)
IS (1) IS6642A (is)
MX (1) MXPA02012506A (is)
NO (1) NO20026029D0 (is)
PL (1) PL358966A1 (is)
SK (1) SK1092003A3 (is)
WO (1) WO2002000645A1 (is)
ZA (1) ZA200209886B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
WO2004020437A1 (en) * 2002-08-29 2004-03-11 H. Lundbeck A/S S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
DE102004027358A1 (de) * 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
JP5379000B2 (ja) * 2006-07-31 2013-12-25 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ウロテンシンｉｉ受容体アンタゴニスト
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
FR2953839A1 (fr) * 2009-12-14 2011-06-17 Sanofi Aventis Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK106395A3 (en) * 1993-03-01 1995-12-06 Merck Sharp & Dohme Treating and treatment or prevention of mental diseases
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
CA2414115A1 (en) 2002-01-03
SK1092003A3 (en) 2003-05-02
HUP0300786A2 (hu) 2003-07-28
JP2004501912A (ja) 2004-01-22
CN1439004A (zh) 2003-08-27
ATE268765T1 (de) 2004-06-15
EP1299380B1 (en) 2004-06-09
KR20030011365A (ko) 2003-02-07
PL358966A1 (en) 2004-08-23
EA200300084A1 (ru) 2003-06-26
ZA200209886B (en) 2003-12-05
EP1299380A1 (en) 2003-04-09
DE60103761D1 (de) 2004-07-15
IL153254A0 (en) 2003-07-06
US20030232822A1 (en) 2003-12-18
NO20026029L (no) 2002-12-16
WO2002000645A1 (en) 2002-01-03
BG107471A (en) 2003-10-31
MXPA02012506A (es) 2003-04-25
AR028736A1 (es) 2003-05-21
CZ20024192A3 (cs) 2003-04-16
BR0112286A (pt) 2003-05-13
NO20026029D0 (no) 2002-12-16
AU2001273882A1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
IS6837A (is) 3-Indólín afleiður sem eru nytsamlegar við meðhöndlun á geðrænum og taugafræðilegum truflunum
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
IS6438A (is) Nýjar asabísýklóoktanafleiður sem eru gagnlegar við meðhöndlun á hjartsláttartruflunum
IS6637A (is) 3-azabísýkló[3.1.0]hexan afleiður sem eru nytsamlegar í meðferð
IS6137A (is) Meðhöndlun á hugsýkistruflunum
IS6694A (is) 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum
AU2002215047A1 (en) Isoquinoline derivatives useful in the treatment of cns disorders
IS6663A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
IS6642A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
DE60111379D1 (de) Indolderivate zum gebrauch in der behandlung von zns-störungen
IS6652A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
IS6643A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
IS6201A (is) Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
IS6619A (is) S-metýl-díhýdró-siprasídón til meðhöndlunar á geðrænum kvillum og augnkvillum
NO20026028L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
IS6200A (is) Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
IS6198A (is) Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
NO20043735L (no) Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
DK1305314T3 (da) Krystallinsk terapeutisk middel